NWBO — NORTHWEST BIOTHERAPEUTICS INC

—
OTC · Health Care · Pharmaceuticals · CIK 1072379 ·
Last close
$0.15
Market Cap
$250.73M
52W High
$0.34
52W Low
$0.14
ADV30
5,469,105
Next earnings
2026-11-13
Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 883,000 — -9,939,000 -28,762,000 76,137,000 725,000 132,839,000
Jun 2026 807,000 — -11,605,000 -9,221,000 75,941,000 595,000 121,115,000
Mar 2026 494,000 — -10,900,000 -3,069,000 80,051,000 1,786,000 130,595,000
Dec 2025 672,000 — -13,504,000 1,388,000 81,290,000 3,040,000 141,570,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-48,335,000
Investing CF
$-1,745,000
Financing CF
$41,727,000
CapEx
$-1,434,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,515,951,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-28,846,000
Pretax Income TTM
$-38,268,000
Interest Exp TTM
$9,422,000
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,173,000
EBITDA
$-47,605,000
Free Cash Flow
$-35,601,376
Enterprise Value
$333,176,352
Total Cash
$595,000
Total Debt
$56,441,000
Shares Out
1,705,637,993
Trailing EPS
$-0.03
Book Value
$-0.03
ROE
—
ROA
-59.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,378,000 -59,914,000 -60,162,000 81,290,000 141,570,000 -60,280,000 -44,763,000
Dec 2024 1,382,000 -66,508,000 -83,778,000 26,728,000 121,215,000 -94,487,000 -57,017,000
Dec 2023 1,932,000 -55,508,000 -62,599,000 27,865,000 93,638,000 -65,773,000 -53,637,000
Dec 2022 1,683,000 -67,181,000 -105,032,000 31,323,000 159,426,000 -128,103,000 -52,775,000

TTM Snapshot

Revenues TTM
$2,173,000
NetIncome TTM
$-37,731,000
OpCashFlow TTM
—
Assets (Latest)
$75,941,000
Forward EPS
$-0.07

Peers — same industry

TickerNameMarket CapLastDaily %
CAMP Camp4 Therapeutics Corp $251.02M $4.00 —
ENTA ENANTA PHARMACEUTICALS INC $253.10M $8.69 —
PRE Prenetics Global Ltd $248.19M $16.33 —
QTTB Q32 Bio Inc. $258.24M $8.63 —
LFCR LIFECORE BIOMEDICAL, INC. \DE\ $242.22M $6.39 —

News headlines (Yahoo Finance, 1h cache)

Northwest Biotherapeutics: Q3 Earnings Snapshot
2026-11-13 21:53 · Yahoo
Northwest Biotherapeutics Announces Expansion of Its Technical Team
2026-10-26 15:16 · Yahoo
Northwest Biotherapeutics Announces NHSBT Collaboration to Support DCVax-L Production in the UK
2026-10-09 13:55 · Yahoo
Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production
2026-10-08 20:53 · Yahoo
Northwest Biotherapeutics Highlights Personalized Cancer Vaccine Approach at NHS Oncology Conference
2026-10-06 14:51 · Yahoo
Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
2026-10-06 07:00 · Yahoo
Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses
2026-07-08 18:24 · Yahoo
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
2026-04-30 16:30 · Yahoo
Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company
2026-08-06 15:58 · Yahoo
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
2026-07-02 18:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.